DrugPatentWatch Database Preview

IBUPROFEN - Generic Drug Details

« Back to Dashboard

What are the generic sources for ibuprofen and what is the scope of patent protection?

Ibuprofen is the generic ingredient in forty-four branded drugs marketed by Glaxosmithkline, Amneal Pharms, Ascent Pharms Inc, Aurobindo Pharma Ltd, Bionpharma Inc, Contract Pharmacal, Humanwell Puracap, Marksans Pharma, P And L Dev Llc, Sofgen Pharms, Strides Pharma, Bayer, Cumberland Pharms, J And J Consumer Inc, Guardian Drug, L Perrigo Co, Tris Pharma Inc, Mcneil, Moberg Pharma North, Perrigo, Abbott, Actavis Mid Atlantic, Akorn, Aptapharma Inc, Arise, P And L, Taro, Mcneil Consumer, Mcneil Ped, Lederle, Basf, Alra, Pliva, Amneal Pharms Ny, Ani Pharms Inc, Avema Pharma, Dr Reddys La, Dr Reddys Labs Inc, Granules, Granules India, Halsey, Hec Pharm, Ivax Sub Teva Pharms, Leiner, LNK, Merro Pharm, Mylan, Northstar Hlthcare, OHM, Ohm Labs, Par Pharm, Perrigo Pharms Co, Perrigo R And D, Purepac Pharm, Rising, Sandoz, Shandong Xinhua, Sun Pharm Industries, Superpharm, Teva, Ultratab Labs Inc, Vintage Pharms, Watson Labs, Yichang Humanwell, Bristol Myers, Xgen Pharms, Recordati Rare, Forest Labs, Actavis Elizabeth, Barr Labs Inc, and Dr Reddys Labs Ltd, and is included in two hundred and seventeen NDAs. There are fourteen patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Ibuprofen has sixty-two patent family members in eighteen countries.

There are sixty-four drug master file entries for ibuprofen. Two hundred and eight suppliers are listed for this compound. There is one tentative approval for this compound.

Summary for IBUPROFEN

International Patents:	62
US Patents:	14
Tradenames:	44
Applicants:	71
NDAs:	217
Drug Master File Entries:	64
Suppliers / Packagers:	208
Bulk Api Vendors:	170
Clinical Trials:	689
Patent Applications:	7,220
Formulation / Manufacturing:	see details
Drug Prices:	Drug price trends for IBUPROFEN
Drug Sales Revenues:	Drug sales revenues for IBUPROFEN
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for IBUPROFEN
DailyMed Link:	IBUPROFEN at DailyMed

See drug prices for IBUPROFEN

See drug sales revenues for IBUPROFEN

Recent Clinical Trials for IBUPROFEN

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Apsen Farmaceutica S.A.	Phase 2
Children's Hospital of Fudan University	Phase 4
Fraser Health	N/A

See all IBUPROFEN clinical trials

Generic filers with tentative approvals for IBUPROFEN

Applicant	Application No.	Strength	Dosage Form
		800MG; 26.6MG	TABLET;ORAL

The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.

Pharmacology for IBUPROFEN

Drug Class	Nonsteroidal Anti-inflammatory Drug
Mechanism of Action	Cyclooxygenase Inhibitors

Medical Subject Heading (MeSH) Categories for IBUPROFEN

Analgesics, Non-Narcotic

Anti-Inflammatory Agents, Non-Steroidal

Cyclooxygenase Inhibitors

Paragraph IV (Patent) Challenges for IBUPROFEN

Tradename	Dosage	Ingredient	NDA	Submissiondate
INFANT'S ADVIL	SUSPENSION/DROPS;ORAL	ibuprofen	020812	2007-06-29
PEDIATRIC ADVIL	SUSPENSION/DROPS;ORAL	ibuprofen	020812	2007-06-29
CHILDREN'S MOTRIN	TABLET, CHEWABLE;ORAL	ibuprofen	020601
JUNIOR STRENGTH MOTRIN	TABLET, CHEWABLE;ORAL	ibuprofen	020601
CHILDREN'S MOTRIN	SUSPENSION/DROPS;ORAL	ibuprofen	020603

US Patents and Regulatory Information for IBUPROFEN

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Strides Pharma	IBUPROFEN	ibuprofen	TABLET;ORAL	206989-001	Jun 29, 2018		OTC	No	No
Basf	IBU	ibuprofen	TABLET;ORAL	070099-001	Mar 29, 1985		DISCN	No	No
Contract Pharmacal	IBUPROFEN	ibuprofen	TABLET;ORAL	074931-001	Jul 20, 1998		DISCN	No	No
Strides Pharma	IBUPROFEN	ibuprofen	TABLET;ORAL	078329-001	Feb 5, 2009	AB	RX	No	No
Sofgen Pharms	IBUPROFEN	ibuprofen	CAPSULE;ORAL	203599-001	Sep 7, 2016		OTC	No	No
Humanwell Puracap	IBUPROFEN	ibuprofen	CAPSULE;ORAL	206568-001	Jun 21, 2016		OTC	No	No
Amneal Pharms	IBUPROFEN	ibuprofen	TABLET;ORAL	079233-001	Mar 18, 2014		OTC	No	No

Expired US Patents for IBUPROFEN

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Bionpharma Inc	MIDOL LIQUID GELS	ibuprofen	CAPSULE;ORAL	021472-001	Oct 18, 2002
Glaxosmithkline	CHILDREN'S ADVIL	ibuprofen	SUSPENSION;ORAL	020589-001	Jun 27, 1996
Mcneil Ped	MOTRIN	ibuprofen	TABLET, CHEWABLE;ORAL	020135-001	Nov 16, 1994
J And J Consumer Inc	CHILDREN'S MOTRIN	ibuprofen	SUSPENSION;ORAL	020516-001	Jun 16, 1995
J And J Consumer Inc	CHILDREN'S MOTRIN	ibuprofen	TABLET, CHEWABLE;ORAL	020601-001	Nov 15, 1996
Mcneil Ped	MOTRIN	ibuprofen	TABLET, CHEWABLE;ORAL	020135-001	Nov 16, 1994
J And J Consumer Inc	JUNIOR STRENGTH MOTRIN	ibuprofen	TABLET, CHEWABLE;ORAL	020601-003	Nov 15, 1996

International Patents for IBUPROFEN

Country	Patent Number	Estimated Expiration
Canada	2754922
South Africa	200504239
Turkey	200501948
Spain	2694506
European Patent Office	2453742
World Intellectual Property Organization (WIPO)	2010105129
Canada	2767971